Universal Beteiligungs Und Servicegesellschaft Mb H Biotechnology

Universal Beteiligungs Und Servicegesellschaft Mb H

$47.1 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
SRRK Scholar Rock Holding Corp	$2.06B	$512,000 0.0% of portfolio	15,942	Q1 2025 New
SWTX Spring Works Therapeutics, Inc.	$2.93B	$478,000 0.0% of portfolio	10,846	Q1 2025 New
AKRO Akero Therapeutics, Inc.	$2.41B	$462,000 0.0% of portfolio	11,436	Q1 2025 New
NTLA Intellia Therapeutics, Inc.	$1.03B	$462,000 0.0% of portfolio	65,000	Q1 2025 New
SVRA Savara Inc	$275M	$381,000 0.0% of portfolio	137,694	Q1 2025 New
APLS Apellis Pharmaceuticals, Inc.	$2.19B	$353,000 0.0% of portfolio	16,159	Q1 2025 New
SMMT Summit Therapeutics Inc.	$5.55B	$308,000 0.0% of portfolio	15,980	Q1 2025 New
CLDX Celldex Therapeutics, Inc.	$1.05B	$269,000 0.0% of portfolio	14,834	Q1 2025 New
DNLI Denali Therapeutics Inc.	$1.86B	$254,000 0.0% of portfolio	18,699	Q1 2025 New
NRIX Nurix Therapeutics, Inc.	$530M	$223,000 0.0% of portfolio	18,830	Q1 2025 New
VKTX Viking Therapeutics, Inc.	$2.46B	$205,000 0.0% of portfolio	8,519	Q1 2025 New
PTGX Protagonist Therapeutics, Inc	$2.7B	$202,000 0.0% of portfolio	4,196	Q1 2025 New
SNDX Syndax Pharmaceuticals Inc	$583M	$178,000 0.0% of portfolio	14,560	Q1 2025 New
ARWR Arrowhead Pharmaceuticals, Inc.	$1.58B	$173,000 0.0% of portfolio	13,622	Q1 2025 New
ROIV Roivant Sciences Ltd.	$8.1B	$165,000 0.0% of portfolio	16,400	Q4 2024 New
RCKT Rocket Pharmaceuticals, Inc.	$255M	$142,000 0.0% of portfolio	21,406	Q1 2025 New
RCUS Arcus Biosciences, Inc.	$661M	$138,000 0.0% of portfolio	17,631	Q1 2025 New
XNCR Xencor Inc	$549M	$135,000 0.0% of portfolio	12,733	Q1 2025 New
BCRX Biocryst Pharmaceuticals Inc	$1.61B	$125,000 0.0% of portfolio	16,704	Q1 2025 New
MNKD Mannkind Corp	$1.01B	$123,000 0.0% of portfolio	24,528	Q1 2025 New
PBYI Puma Biotechnology, Inc.	$159M	$116,000 0.0% of portfolio	39,308	Q1 2025 New
NVAX Novavax Inc	$565M	$98,000 0.0% of portfolio	15,407	Q1 2025 New
ZNTL Zentalis Pharmaceuticals, Inc.	$81.5M	$81,000 0.0% of portfolio	51,061	Q1 2025 New
GERN Geron Corp	$484M	$63,000 0.0% of portfolio	39,643	Q1 2025 New
CTMX Cytom X Therapeutics, Inc.	$158M	$62,000 0.0% of portfolio	97,123	Q1 2025 New
IOVA Iovance Biotherapeutics, Inc.	$494M	$57,000 0.0% of portfolio	17,191	Q1 2025 New
RXRX Recursion Pharmaceuticals, Inc.	$1.18B	$57,000 0.0% of portfolio	10,829	Q1 2025 New
PLRX Pliant Therapeutics, Inc.	$76.4M	$24,000 0.0% of portfolio	18,065	Q1 2025 New
EDIT Editas Medicine, Inc.	$231M	$15,000 0.0% of portfolio	13,100	Q1 2025 New
FGEN Fibrogen Inc	$723M	$5,000 0.0% of portfolio	17,327	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Universal Beteiligungs Und Servicegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Universal Beteiligungs Und Servicegesellschaft Mb H with notifications on news.